McLaughlin Hughes (“McLaughlin” or the “Firm”) is a specialized advisory and principal investment Firm focused on advising founders,   operators and investors as they create new medical technologies, finance clinical trials and execute commercialization strategies.  The Firm conceptualizes and executes financings and leads acquisition/divestiture processes to help clients achieve growth, liquidity and partnership objectives.

Client profiles range from large, Fortune 500 healthcare operators to high potential, early stage innovators to PE-backed commercial operators.

During its involvement in transactional work and principal investing, the leadership of McLaughlin Hughes advanced the strategic and economic interests of several notable organizations as sources of investment, transactional counterparties or clients. Healthcare focused IBs, VC/PE firms and high-profile operators are all represented in the Firms current and historical activity list.

As a performance driven institution, the Firm's initiatives are managed to drive optimal results for client mandated transactions. Each transaction is thoughtfully designed and carefully executed to achieve optimized valuation levels, fastest process execution timing and the highest certainty of close.